Random matrix ensembles of time correlation matrices to analyze visual lifelogs

Visual lifelogging is the process of automatically recording images and other sensor data for the purpose of aiding memory recall. Such lifelogs are usually created using wearable cameras. Given the vast amount of images that are maintained in a visual lifelog, it is a significant challenge for users to deconstruct a sizeable collection of images into meaningful events. In this paper, random matrix theory (RMT) is applied to a cross-correlation matrix C, constructed using SenseCam lifelog data streams to identify such events. The analysis reveals a number of eigenvalues that deviate from the spectrum suggested by RMT. The components of the deviating eigenvectors are found to correspond to “distinct significant events” in the visual lifelogs. Finally, the cross-correlation matrix C is cleaned by separating the noisy part from the non-noisy part. Overall, the RMT technique is shown to be useful to detect major events in SenseCam images

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Background: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. Those trial participants with hypoxia (oxygen saturation <92% on air or requiring oxygen therapy) and evidence of systemic inflammation (C-reactive protein ≥75 mg/L) were eligible for random assignment in a 1:1 ratio to usual standard of care alone versus usual standard of care plus tocilizumab at a dose of 400 mg–800 mg (depending on weight) given intravenously. A second dose could be given 12–24 h later if the patient's condition had not improved. The primary outcome was 28-day mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN (50189673) and ClinicalTrials.gov (NCT04381936). Findings: Between April 23, 2020, and Jan 24, 2021, 4116 adults of 21 550 patients enrolled into the RECOVERY trial were included in the assessment of tocilizumab, including 3385 (82%) patients receiving systemic corticosteroids. Overall, 621 (31%) of the 2022 patients allocated tocilizumab and 729 (35%) of the 2094 patients allocated to usual care died within 28 days (rate ratio 0·85; 95% CI 0·76–0·94; p=0·0028). Consistent results were seen in all prespecified subgroups of patients, including those receiving systemic corticosteroids. Patients allocated to tocilizumab were more likely to be discharged from hospital within 28 days (57% vs 50%; rate ratio 1·22; 1·12–1·33; p<0·0001). Among those not receiving invasive mechanical ventilation at baseline, patients allocated tocilizumab were less likely to reach the composite endpoint of invasive mechanical ventilation or death (35% vs 42%; risk ratio 0·84; 95% CI 0·77–0·92; p<0·0001). Interpretation: In hospitalised COVID-19 patients with hypoxia and systemic inflammation, tocilizumab improved survival and other clinical outcomes. These benefits were seen regardless of the amount of respiratory support and were additional to the benefits of systemic corticosteroids. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

(33)S MAS NMR of a disordered sulfur-doped silicate: signal enhancement via RAPT, QCPMG and adiabatic pulses

Three different signal enhancement techniques have been applied to (33)S magic-angle spinning nuclear magnetic resonance (MAS NMR) of a disordered silicate containing 1.15 wt% (33)S. Partial saturation of the satellite transitions was achieved using a rotor-assisted population transfer (RAPT) pulse sequence, resulting in a signal enhancement of 1.63, albeit with a slight distortion of the line shape due to selective excitation. Adiabatic inversion of the satellite transitions by various amplitude-and frequency-modulated pulse shapes (such as hyperbolic secant and wideband uniform-rate smooth truncation) was also attempted, resulting in a signal enhancement of up to 1.85, with no apparent line shape distortion. Quadrupolar Carr-Purcell-Meiboom-Gill (QCPMG) and RAPT-QCPMG sequences were also used, both of which yielded spikelet spectra that accurately reflected the MAS line shape with a greatly improved signal-to-noise ratio. It is hoped that this study demonstrates that (33)S solid-state MAS NMR is now feasible even on disordered, low-sulfur-content systems

Common genetic variants influence human subcortical brain structures

The highly complex structure of the human brain is strongly shaped by genetic influences1. Subcortical brain regions form circuits with cortical areas to coordinate movement2, learning, memory3 and motivation4, and altered circuits can lead to abnormal behaviour and disease2. To investigate how common genetic variants affect the structure of these brain regions, here we conduct genome-wide association studies of the volumes of seven subcortical regions and the intracranial volume derived from magnetic resonance images of 30,717 individuals from 50 cohorts. We identify five novel genetic variants influencing the volumes of the putamen and caudate nucleus. We also find stronger evidence for three loci with previously established influences on hippocampal volume5 and intracranial volume6. These variants show specific volumetric effects on brain structures rather than global effects across structures. The strongest effects were found for the putamen, where a novel intergenic locus with replicable influence on volume (rs945270; P = 1.08 × 10−33; 0.52% variance explained) showed evidence of altering the expression of the KTN1 gene in both brain and blood tissue. Variants influencing putamen volume clustered near developmental genes that regulate apoptosis, axon guidance and vesicle transport. Identification of these genetic variants provides insight into the causes of variability in human brain development, and may help to determine mechanisms of neuropsychiatric dysfunction